Cabaletta Bio, Inc.

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US12674W1099
USD
2.56
0.22 (9.4%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Cabaletta Bio, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-115.00
-67.00
-52.00
-46.00
-33.00
-16.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
1.00
0.00
-4.00
5.00
1.00
-1.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-88.00
-53.00
-46.00
-34.00
-26.00
-16.00
Cash Flow from Investing Activities
47.00
-22.00
-27.00
5.00
-7.00
0.00
Cash Flow from Financing Activities
11.00
187.00
32.00
48.00
0.00
119.00
Net Cash Inflow / Outflow
-29.00
111.00
-40.00
20.00
-34.00
103.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Cabaletta Bio, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-115.864
-97.0080000000029
-18.00
-19.44%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
1.611
-75.8220000000023
76.00
102.12%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-88.222
-151.026000000005
63.00
41.58%
Cash Flow from Investing Activities
47.289
-0.938000000000028
47.00
5141.47%
Cash Flow from Financing Activities
11.677
253.890000000008
-242.00
-95.40%
Net Cash Inflow / Outflow
-29.276
101.788000000003
-130.00
-128.76%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.02
-0.138000000000004
0.00
85.51%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is -64.75% vs -15.46% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-88.22
-53.55
-64.75%